New hope for tough blood cancer: trial tests Two-Drug attack
NCT ID NCT07288814
Summary
This study is testing a new combination of two drugs, mitoxantrone liposome and enlonstobart, for adults with a type of blood cancer called peripheral T-cell lymphoma that has come back or not responded to previous treatments. The main goals are to find the safest and most effective dose of the combination and to see how well it works at shrinking the cancer. This is an early-phase study (Phase 1b/2) that will enroll about 43 participants who have already tried other standard therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.